Financial Consulate’s Guardant Health GH Stock Holding History

Financial Consulate’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$357	Buy	+2	New	+$327	﹤0.01%	1543

Other funds holding GH

Slow Capital Greenbrae, California $890M AUM 40.96% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Financial Consulate's GH Position: Q3 2026 in Review

Financial Consulate opened a new position in Guardant Health (GH) in Q3 2026: 2 shares worth $357. The stake represents ﹤0.01% of the portfolio and ranks #1543 among its holdings.

112 funds tracked by Wall St. Rank hold GH as of Q3 2026.

Financial Consulate held 2 shares of Guardant Health worth $357 as of Q3 2026.
Guardant Health was a new Financial Consulate position in Q3 2026.
Guardant Health made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1543 holding.
112 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.